F. Khemissa Akouz
F. Khemissa Akouz publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology and Colorectal Cancer Surgical Treatments.
- World rank
- #1,611,546 of 7,710,434 ranked researchers
- Rank in France
- #71,821 of 324,115
- Works
- 33
- Citations
- 586
- Citations per work
- 17.8
What does F. Khemissa Akouz research?
F. Khemissa Akouz's work is mostly in Medicine (81%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2780.7%
- Medicine2780.7%
- Everything else411.3%
- Life Sciences38.0%
- 1Oncology48% of their works
- 2Surgery10% of their works
- 3Pulmonary and Respiratory Medicine9% of their works
- 4Cancer Research8% of their works
- 5Pathology and Forensic Medicine8% of their works
- 6Hepatology6% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Genetic factors in colorectal cancer
- Cancer Genomics and Diagnostics
- Pancreatic and Hepatic Oncology Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Immunotherapy and Biomarkers
Which keywords describe F. Khemissa Akouz's research?
The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, Adjuvant Chemotherapy, Neoadjuvant Therapy, Clinical Practice Guidelines, Tumor Microenvironment and Chemotherapy-Induced Peripheral Neuropathy.
- Liver Cancer
- Hepatocellular Carcinoma
- Pancreatic Cancer
- Cancer Genomics
- Rectal Cancer
- Molecular Characterization
- Chemotherapy-Induced Peripheral Neuropathy
- Clinical Practice Guidelines
- Adjuvant Chemotherapy
- Cetuximab
- Chemotherapy
- KRAS Mutations
- Neoadjuvant Therapy
- Tumor Microenvironment
- Microsatellite Instability
- Preoperative Chemoradiotherapy
- Taxanes
- Mutational Signatures
- Surgical Complications
- Immune Checkpoint Blockade
- PD-1 and PD-L1
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy222 topics
- Cetuximab171 topic
- KRAS Mutations171 topic
- Adjuvant Chemotherapy122 topics
- Neoadjuvant Therapy112 topics
- Clinical Practice Guidelines102 topics
- Tumor Microenvironment92 topics
- Chemotherapy-Induced Peripheral Neuropathy61 topic
- Microsatellite Instability61 topic
- Molecular Characterization61 topic
- Preoperative Chemoradiotherapy61 topic
- Rectal Cancer61 topic
- Taxanes61 topic
- Cancer Genomics51 topic
- Mutational Signatures51 topic
- Pancreatic Cancer51 topic
- Surgical Complications51 topic
- Hepatocellular Carcinoma41 topic
- Immune Checkpoint Blockade41 topic
- Liver Cancer41 topic
- PD-1 and PD-L141 topic
Where does F. Khemissa Akouz work?
F. Khemissa Akouz's main affiliation in the publication record is Centre Hospitalier de Perpignan, France.
How many publications and citations does F. Khemissa Akouz have?
OpenAlex counts 33 works and 586 citations for F. Khemissa Akouz, an h-index of 11, ranking #1,611,546 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about F. Khemissa Akouz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.